Marco Miceli | Biology and Life Sciences | Best Paper Award

Published on by Research Awards

Dr. Marco Miceli | Biology and Life Sciences | Best Paper Award 

CEINGE-Biotecnologie Avanzate Franco Salvatore | Italy

Dr. Marco Miceli is an Italian biomedical researcher with over two decades of continuous experience in molecular biology, epigenetics, genetics, and translational biomedical research, developed within leading academic and research institutions in Italy. Born on 20 February 1973, he is currently engaged at CEINGE–Biotecnologie Avanzate “Franco Salvatore” in Naples, where since October 2022 he has been working under a fixed-term collaboration contract within the national project “TASK FORCE 2022 COVID-19”. In this role, he serves as Head of the Level III Biosafety Laboratory (BSL-3), operating under the scientific supervision of Prof. Massimo Zollo, with responsibilities encompassing high-containment laboratory management, advanced virological research, and biosafety compliance. Between 2020 and 2022, Dr. Miceli worked at the University of Naples Federico II, Department of Neurosciences, Reproductive Sciences and Odontostomatology, contributing to a CDA-funded project focused on the molecular etiology of syndromic and non-syndromic genetic hearing loss, including genotype–phenotype correlations and functional characterization of pathogenic variants. His research career has been strongly rooted at CEINGE and associated institutes, where he has held multiple research appointments since 2019, collaborating on projects spanning molecular diagnostics, functional genomics, and advanced cellular models. Earlier in his career, he served as a fixed-term researcher at the IRCCS SDN Research Institute, working on innovative projects involving amniocyte stem cells, 3D scaffolds for bone tissue engineering, and epigenetic profiling of immune cells in metabolic disorders. From 2005 onward, Dr. Miceli played a sustained role in several nationally and EU-funded research programs, including EPITRON, ATLAS, APO-SYS, and PON-SIRTT-IN, primarily under the scientific guidance of Prof. Lucia Altucci. His work during this period focused on epigenetic regulation of gene expression, chromatin immunoprecipitation (ChIP), real-time PCR, histone deacetylase complexes, apoptosis regulation, and cancer epigenetics. Dr. Miceli’s long-standing expertise spans molecular genetics, chromatin biology, lentiviral systems, stem cell models, and translational biomedical research, making him a highly experienced and reliable contributor to multidisciplinary research initiatives at the interface of basic science, clinical research, and advanced biotechnological applications.

Citation Metrics (Google Scholar)

3000
2000
1000
500
400
300
200
100
50
30
10
0

Citations
2756

Documents
39

h-index
25

Citations

Documents

h-index

View Google Scholar Profile
   View Orcid Profile

Featured Publications

Hou-Qun Ying | Toxicology and Pharmaceutical Science | Research Excellence Award

Published on by Research Awards

Prof. Hou-Qun Ying | Toxicology and Pharmaceutical Science | Research Excellence Award 

The Second Affiliated Hospital of Nanchang University | China

Dr. Hou-Qun Ying, PhD, born on July 18, 1985, in Shangrao, Jiangxi Province, China, is an accomplished clinical scientist specializing in cancer biomarkers, inflammation-related indices, molecular epidemiology, and therapeutic response prediction. He currently serves as the Vice Director of the Department of Clinical Laboratory Medicine at The Second Affiliated Hospital of Nanchang University, where he plays a leading role in translational research, diagnostic innovation, and clinical laboratory management. Dr. Ying earned his Ph.D. in Clinical Laboratory Diagnosis from Southeast University (2013–2016), after completing his Master of Medicine in Pathogenic Biology at Dali University and his Bachelor of Medicine in Medical Laboratory Science from Tianjin Medical University. His academic and professional journey reflects strong expertise in cancer diagnostics, genetic polymorphisms, biomarker development, and precision medicine. Dr. Ying has successfully led multiple competitive research grants, including the National Natural Science Foundation of China Youth Fund (2018–2020), exploring Hippo-pathway-related genetic variations and EGFR-TKI resistance in non-small cell lung cancer, and the 2024–2027 Regional Fund focusing on SP1 transcription factor–related genetic variations as biomarkers for bevacizumab resistance in metastatic colorectal cancer. His research contributions span more than 70 peer-reviewed publications, with many as first, co-first, or corresponding author in high-impact journals such as Scientific Reports, Oncotarget, Cancer Medicine, Therapeutic Advances in Medical Oncology, Frontiers in Oncology, Pharmacological Research, Biomarkers, Future Oncology, and J Inflammation Research. His studies have provided pivotal insights into inflammatory markers such as fibrinogen-to-pre-albumin ratio, albumin-to-fibrinogen ratio, dNLR, PLR, and novel composite biomarkers for cancer prognosis, treatment response prediction, early diagnosis, and recurrence risk stratification. He has also made influential contributions to colorectal cancer, gastric cancer, gallbladder carcinoma, hepatocellular carcinoma, and NSCLC through biomarker innovation, clinical prediction models, and meta-analytic evaluations. As a corresponding author, Dr. Ying has developed and validated numerous inflammation-based and genetic biomarker signatures, such as FPR, ADS score, MLPAS, CCMLP, and chronic inflammation indices, improving precision therapeutic decisions for chemotherapy, bevacizumab, 5-FU–based regimens, and TKIs. Additionally, his collaborative work extends to machine learning applications in early gastric cancer prediction, molecular mechanisms underlying cancer progression, and multi-omics approaches. With a distinguished record of scientific leadership, grant success, and impactful publications, Dr. Ying continues to advance clinical oncology diagnostics and personalized treatment strategies through rigorous research, innovation, and interdisciplinary collaboration.

Profiles: Scopus | Orcid

Featured Publications

Peng, Y., Shang, R., Wang, Z.-J., Ye, Q.-Y., Tang, X.-Y., Cheng, X.-X., & Ying, H.-Q. (2025). Chronic inflammatory comprehensive signature predicts oxaliplatin and 5-fluorouracil benefit in early colorectal cancer. Drug Design, Development and Therapy. https://doi.org/10.2147/DDDT.S556619

Lu, Y., Ye, Q.-Y., Mei, O., Li, Y.-N., Peng, Y., Ying, H.-Q., & Cheng, X.-X. (2025). Chronic inflammation index-based tumor subsite classification correlated with chemotherapy benefit and survival outcomes in stage II–III colorectal cancer. Journal of Inflammation Research. https://doi.org/10.2147/JIR.S517378

Ye, Q.-Y., Wang, Y.-Y., Wang, Z.-J., Lu, M., Peng, H.-X., Wang, X., Cheng, X.-X., & Ying, H.-Q. (2025). Robust predictive performance of MLPAS and CCMLP for clinical outcome and risk stratification in patients with colorectal cancer. Journal of Inflammation Research. https://doi.org/10.2147/JIR.S498028

Tian, H., Liu, Z., Zhang, Z., Zhang, L., Zong, Z., Liu, J., Ying, H., & Li, H. (2023). Clinical significance of fibrinogen and platelet to pre-albumin ratio in predicting the prognosis of advanced gastric cancer. Journal of Inflammation Research. https://doi.org/10.2147/JIR.S412033

Ying, H.-Q., Liao, Y.-C., Luo, Y.-R., Xiong, G., Huang, Y., Nie, R.-W., Xiong, C.-F., & Cheng, X.-X. (2021). Cancer-elicited inflammation attenuates response and outcome in tyrosine kinase inhibitor naïve patients with advanced NSCLC. Pharmacological Research, 105734. https://doi.org/10.1016/j.phrs.2021.105734

Ying, H.-Q., You, X.-H., Liao, Y.-C., Sun, F., & Cheng, X.-X. (2021). High-grade inflammation attenuates chemosensitivity and confers poor survival of surgical stage III CRC patients. Frontiers in Oncology, 11, 580455. https://doi.org/10.3389/fonc.2021.580455

Liao, Y.-C., Ying, H.-Q., Huang, Y., Luo, Y.-R., Xiong, C.-F., Nie, R.-W., Li, X.-J., & Cheng, X.-X. (2021). Role of chronic inflammatory ratios in predicting recurrence of resected patients with stage I–III mucinous colorectal adenocarcinoma. Cancer Management and Research, 13, 303758. https://doi.org/10.2147/CMAR.S303758

Yves Julien Mbama Biloa | Medicine and Health Sciences | Young Scientist Award

Published on by Research Awards

Mr. Yves Julien Mbama Biloa | Medicine and Health Sciences | Young Scientist Award 

Jean Monnet University | France

Mr. Yves Julien MBAMA BILOA is a dedicated emerging public health scholar whose research, teaching, and professional work converge around preventive health, clinical innovation, and population well-being. Born on May 16, 1996, in Cameroon, he is currently completing his Ph.D. in Public Health at Jean Monnet University of Saint-Étienne, France, where he will defend his doctoral thesis on December 18, 2025. His doctoral research—focused on developing a preventive clinical practice framework during the transition to retirement using the Delphi consensus method—positions him at the forefront of preventive healthcare innovation for aging populations. With a strong academic foundation in human biology, animal physiology, and epidemiology, he holds a Master’s degree in Biology and Physiology of Animal Organisms (2021) and a Bachelor’s degree in Human Biology and Health, both from the University of Douala, Cameroon. His expertise extends across qualitative and quantitative research methods, statistics, health promotion, and digital health applications. Yves has developed a robust professional background that includes university-level teaching, research contributions, and entrepreneurial experience. As a Public Health Teacher at Université Claude Bernard Lyon 1 and IRFSS-FI Rhône Alpes, he has delivered courses on social inequalities in health, nursing practices, and international mobility, shaping the perspectives of future healthcare professionals. His entrepreneurial initiative as the Founder of the Center for Statistical Processing and Analysis in Douala demonstrates his leadership in offering methodological support, statistical consulting, and academic mentorship to students and researchers. His skill set spans statistical analysis, epidemiological assessment, scientific writing, and the application of artificial intelligence in health. His publication record reflects growing expertise in preventive healthcare, retirement-transition health strategies, and emerging health challenges. He has authored and co-authored peer-reviewed articles in reputable journals such as Public Health, Journal of Public Health (Berlin), BMC Infectious Diseases, and Journal of Health, Population and Nutrition. His works include a Delphi-based preventive clinical practice framework, a scoping review on periodic health examinations during retirement transition, a mixed-methods protocol for evaluating Long Covid interventions (SPACO+), and studies on cardioprotective effects of methotrexate and metabolic syndrome among students. His research aims to strengthen health systems, empower healthcare decision-making, and enhance preventive care models, especially within the contexts of aging, chronic diseases, and digital health transformation. After completing his Ph.D., he intends to advance his expertise in health prevention, mental health, digital health, and health system improvement, contributing impactful and evidence-based insights to global public health

Profiles: Scopus | Orcid

Featured Publications

Development of a preventive clinical practice framework for transition to retirement

Mbama Biloa, Y. J., Rozand, V., Oriol, M., Guindo, Y., Botelho-Nevers, E., & Bongue, B. (2025). Development of a preventive clinical practice framework for transition to retirement: A Delphi consensus of French physicians. Public Health, 249, 106003.

SPACO+: A mixed methods protocol for assessing the effectiveness of an educative intervention in patients with Long Covid

Kamdem, O. L., Dupre, C., Heugno, V., Baudot, A., Essangui, E., Blanquet, M., Guercon, N., Fanget, M., Bayet, S., Vericel, M. P., et al., & Mbama Biloa, Y. J. (2025). SPACO+: A mixed methods protocol to assessing the effectiveness of an educative intervention in patients with Long Covid. BMC Infectious Diseases, 25, 623.

Periodic health examination during transition to retirement: A scoping review

Mbama Biloa, Y. J., Rozand, V., Kamdem, L., Regnier-Denois, V., Botelho-Nevers, E., & Bongue, B. (2025). Periodic health examination during transition to retirement: A scoping review. Journal of Public Health (Berlin).

Unveiling the hidden shield: Methotrexate as a cardio-protector in psoriasis

Mai, S., Mbama, Y., Gouttefarde, P., Franck, T., Cizeron, G., Oriol, M., Maccari, F., Trombert, B., Bongué, B., & Perrot, J.-L. (2024). Unveiling the hidden shield: Methotrexate emerges as a cardio-protector in psoriasis—Insights from a scoping review [Preprint]. HAL Archive.

Prevalence of metabolic syndrome and components in rural, semi-urban, and urban areas in Cameroon

Bilog, N. C., Mekoulou Ndongo, J., Bika Lele, E. C., Guessogo, W. R., Assomo-Ndemba, P. B., Ahmadou, … Mbama Biloa, Y. J., … Temfemo, A. (2023). Prevalence of metabolic syndrome and components in rural, semi-urban and urban areas in the littoral region in Cameroon: Impact of physical activity. Journal of Health, Population and Nutrition, 42, 95.

Jing Li | Engineering | Research Excellence Award

Published on by Research Awards

Prof Dr. Jing Li | Engineering | Research Excellence Award

Shenyang University of Technology | China

Dr. Jing Li is a distinguished Professor and Ph.D. Supervisor at Shenyang University of Technology, specializing in electrical machines and apparatus, arc physics, gas-discharge theory, and simulation modeling. With a career dedicated to advancing the science behind electrical switching devices and circuit protection, her research integrates theoretical modeling, experimental validation, and engineering application—particularly in areas involving complex arc discharge dynamics, thermal behavior, and switching reliability of electrical apparatus under extreme operating conditions. Dr. Li has made substantial contributions to the understanding of arc interruption mechanisms, arc-fluid interaction phenomena, contact erosion processes, and high-altitude circuit breaker behavior, addressing pressing challenges relevant to next-generation power systems, high-voltage DC applications, and emerging smart-grid infrastructure. Her research excellence is demonstrated through her role as Principal Investigator for major funded programs, including one National Natural Science Foundation of China (NSFC) project, one province-level major R&D initiative, and six general research projects supported by government science and education agencies. Additionally, she has participated in more than twenty national, provincial, and collaborative research grants, highlighting her strong research leadership and interdisciplinary engagement within China’s advanced electrical engineering research ecosystem. Dr. Li’s achievements have been recognized through numerous prestigious honors, including the Mechanical Science and Technology Progress Award (Second and Third Prizes) and the Liaoning Science and Technology Progress Award (Second Prize). Dr. Li has authored more than 40 peer-reviewed journal papers, with publications appearing in high-impact international and national journals such as the Chemical Engineering Journal, International Journal of Thermal Sciences, Physics of Fluids, Chinese Physics B, Plasma Science and Technology, Proceedings of the CSEE, and Transactions of the China Electrotechnical Society. Her most recent work includes advanced modeling of arc formation, droplet splashing behavior, fluid-chemical coupling during current interruption, and structural improvements in circuit breaker performance, reflecting deep insight into plasma-material interaction and multiphysics coupling. In addition to her research, Dr. Li serves as a reviewer for leading journals including Physics of Fluids, Proceedings of the CSEE, and Electrical Appliances & Energy Efficiency Management, demonstrating her recognition as a leading expert in the field. Through her scholarly work, project leadership, and contributions to scientific evaluation, Professor Jing Li continues to play a pivotal role in advancing the science and engineering of modern electrical protection systems and applied plasma physics.

Profiles: Scopus | Orcid

Featured Publications

Duan, W., Li, J., Yang, J., Huang, C., Fu, S., Li, Z., & Li, T. (2025). Experimental and numerical study of metal droplet splashing effects on direct current air arc interruption. Physics of Fluids. https://doi.org/10.1063/5.0288531

Duan, W., Li, J., Gao, W., Shi, B., Liu, S., & Cao, Y. (2025). Investigation on heat transfer and fluid flow of arc-flash phenomenon in DC molded case circuit breakers: Model optimization and structural improvement. International Journal of Thermal Sciences. https://doi.org/10.1016/j.ijthermalsci.2025.109919

Xing, C., Liu, S., Li, Y., Xu, J., & Li, J. (2025). Degradation stage division and identification of AC contactor’s contact system. IEEE Sensors Journal. https://doi.org/10.1109/JSEN.2025.3527471

Duan, W., Li, J., Bao, Y., Huang, H., Yang, J., Liu, S., & Cao, Y. (2025). Interaction between arc root stagnation-transition and contact erosion during direct current air circuit breaker interruption. Physics of Fluids. https://doi.org/10.1063/5.0239389

Li, J., Yin, Y., Peng, S., Liu, S., Fu, Y., & Yu, L. (2025). The improvement of self-excited small current breaking of SE-DCCB by magnetic field reconstruction based on the evolution mechanism of arc root transition. Physics of Plasmas. https://doi.org/10.1063/5.0230317

Peng, S., Li, J., Liu, S., & Cao, Y. (2024). Research on the liquid metal bridge formation process at contact separation moment of DC air circuit breaker. IEEE Transactions on Plasma Science. https://doi.org/10.1109/TPS.2024.3357755

Li, J., Peng, S., Yi, C., Huang, H., Cao, Y., Liu, S., & Zhou, Z. (2024). Optimization research on DC air circuit breaker at high altitudes based on arc root stagnation and arc reverse movement phenomena. Journal of Electrical Engineering & Technology. https://doi.org/10.1007/s42835-023-01633-6

 

Thierry Ngouana Kammalac | Medical Mycology | Best Research Article Award

Published on by Research Awards

Dr. Thierry Ngouana Kammalac | Medical Mycology | Best Research Article Award

Laboratoire Sion| Cameroon

Dr. Ngouana Kammalac Thierry is an accomplished Cameroonian biochemist and medical mycologist with extensive experience in microbial diagnostics, infectious disease research, and biotechnology innovation. He holds a PhD in Biochemistry and Health Sciences (2014), jointly awarded by the University of Montpellier in France and the University of Yaoundé I in Cameroon, where his doctoral work focused on the genetic diversity of Cryptococcus and Candida isolates in HIV-positive patients and their susceptibility to antifungal therapies and medicinal plant extracts. He also holds a Master’s degree in Biochemistry (2009) from the University of Yaoundé I. Dr. Ngouana has built an exceptional career at the intersection of laboratory science, diagnostic technology, and academic instruction. As Director of Zion Biomedical Corporation since 2023, he leads the development and large-scale production of innovative biomedical products, including lateral flow immunochromatographic diagnostic tests, microbial culture media, and specialized staining dyes, contributing to improved diagnostic capacities in the region. Since 2016, he has also served as Director of Zion Medical Laboratory, where he oversees scientific development, clinical diagnostics, and antimicrobial resistance surveillance. His laboratory plays a crucial role in cryptococcal meningitis diagnosis among HIV-infected patients, the establishment of microbial standard operating procedures (SOPs), and the strengthening of Cameroon’s diagnostic infrastructure. Alongside his laboratory leadership, Dr. Ngouana has been an associate lecturer at the Catholic University and the Protestant University of Central Africa since 2015, teaching courses in medical mycology, biochemistry, and bacteriology. He has a strong publication record, contributing to high-impact research on Candida genetic diversity, antifungal resistance, pathogenic yeast epidemiology, and bioactive compounds from medicinal plants. His work has appeared in reputable journals such as Brazilian Journal of Microbiology, American Journal of Microbiological Research, Mycoses, Journal de Mycologie Médicale, Medical Mycology, and Journal of Medical Microbiology. Notable contributions include studies revealing novel genotypes of Candida species, antifungal susceptibility patterns in Africa and Europe, and plant-derived compounds with potent antifungal activity. Dr. Ngouana’s expertise spans molecular diagnostics, PCR, microscopy, microbial culture, infection control, and data analysis, supported by strong research methodology and teamwork competencies. He is an active member of the FAILSAFE Medical Mycology Network, the Cameroonian Society of Microbiology, and the French Society of Medical Mycology, reflecting his engagement in global scientific collaboration and capacity building in medical mycology.

Profiles: Scopus | Orcid

Featured Publications

Ngouana, T. K., Dougue, A. N., Ngouana, V., Tsayem, R. F., Mahamat, Y. H., Boyom, F. F., & Ranque, S. (2025). Vulvo-vaginal candidiasis at the Zion Clinical Laboratory (Yaounde-Cameroon): Risk factors, species distribution and antifungal susceptibility testing. Journal of Medical Mycology,

Kountchou, C. L., Kabtani, J., Dougue, A. N., Nangwat, C., Ekpo, A. I., Ngonde, M. C., Mogo, C. B., Dzoyem, J. P., Ranque, S., & Ngouana, T. K. (2025). Candida krusei (Pichia kudriavzevii) multilocus sequence typing and antifungal susceptibility profile in Cameroon. Brazilian Journal of Microbiology.

Medhat Elshahat | Genetics and Genomics | Editorial Board Member

Published on by Research Awards

Mr. Medhat Elshahat | Genetics and Genomics | Editorial Board Member

Bari University | Italy

Mr. Medhat Saleh is an accomplished researcher and academic specializing in Poultry Breeding and Genetics, currently pursuing his Ph.D. at the Department of Veterinary Medicine, University of Bari “Aldo Moro”, Italy. He also serves as an Assistant Lecturer of Poultry Breeding and Genetics at the Faculty of Agriculture, Benha University, Egypt. His professional journey reflects a consistent commitment to advancing the fields of quantitative genetics, genomics, animal breeding, and bioinformatics, with a particular emphasis on understanding the genetic architecture of complex traits and genomic diversity in livestock species. Mr. Saleh obtained his B.Sc. in Agricultural Science (Animal Production) in 2015 and an M.Sc. in Agricultural Biotechnology in 2019 through a collaborative program between Benha University and the TEMPUS European Union Project. His academic excellence earned him a Ph.D. scholarship at the University of Bari in 2021, where his research focuses on genome-wide association studies (GWAS) and the identification of SNPs and functional genes linked to economically significant traits in poultry. His recent visiting research experience at Wageningen University, the Netherlands (2023–2024), further expanded his expertise in animal breeding and genomics. Throughout his career, Mr. Saleh has actively participated in international conferences and workshops across Italy, Germany, Egypt, and the Netherlands, contributing to scientific discussions on genomic selection, precision livestock farming, and sustainable animal production. His publication record includes numerous peer-reviewed articles in high-impact journals such as British Poultry Science, Livestock Science, and Poultry Science Journal, covering topics like molecular genetics, bioinformatics analyses, and crossbreeding impacts on immunity and growth traits in chickens. Technically proficient, he is skilled in molecular and bioinformatics techniques, including DNA/RNA extraction, PCR, and advanced data analysis using Plink, R, SAS, BLUPF90, and GENALEX. His collaborative research efforts with international scientists underscore his analytical and problem-solving abilities. Mr. Saleh’s professional strengths also encompass strategic planning, critical thinking, teamwork, and communication, enabling him to contribute effectively to academic and applied research environments. With a strong dedication to scientific advancement and sustainable genetic improvement in poultry, Mr. Saleh aims to bridge genomic innovation and animal production for future generations. His growing global research profile positions him as a promising young scientist contributing significantly to the fields of animal genetics, breeding, and biotechnology.

Profiles: Orcid | Google Scholar

Featured Publications

Galgano, M., Pellegrini, F., Fracchiolla, G., Mrenoshki, D., Zarea, A. A. K., Bianco, A., Del Sambro, L., Capozzi, L., Schiavone, A., & Saleh, M. S. (2023). Pilot study on the action of Thymus vulgaris essential oil in treating the most common bacterial contaminants and Salmonella enterica subsp. enterica serovar Derby in poultry litter. Antibiotics, 12(3), 436.

Saleh, M. S., Iraqi, M. M., Khalil, M. H., & Camarda, A. (2020). Crossbreeding analyses and polymorphic associations of gallinacin genes with growth traits in chickens. Livestock Science, 240, 104118.

Saleh, M. S. (2019). Using bioinformatics SNP to improve immune genetic response against some pathogens in poultry. [Master’s thesis, Benha University, in cooperation with TEMPUS European Union Program].

Saleh, M. S., Khalil, M. H., Iraqi, M. M., & Camarda, A. (2021). Polymorphic characterization of gallinacin candidate genes and their molecular associations with growth and immunity traits in chickens. British Poultry Science, 62(2), 180–187.

Pugliese, N., Tinelli, A., Crescenzo, G., Nieddu, M., Baralla, E., Schiavone, A., Zizzo, N., Samarelli, R., Dessì, F., Circella, E., & Saleh, M. S. (2024). Poisoning by Nerium oleander L. in Franconia geese. Animals, 14(4), 612.

Saleh, M. S., Khalil, M. H., Iraqi, M. M., & Camarda, A. (2021). Molecular associations of gallinacin genes with immune response against Salmonella typhimurium in chickens. Livestock Science, 244, 104315.

Saleh, M. S., Landi, V., Derks, M. F. L., Centoducati, G., Groenen, M. A. M., De Palo, P., Ciani, E., Pugliese, N., Circella, E., & Camarda, A. (2025). Genome-wide analyses of genomic diversity, population structure and selection signatures in Italian turkey populations. Poultry Science, 104(1), 104543.

Michal Galek-Aldridge | Health Sciences | Best Scholar Award

Published on by Research Awards

Mr. Michal Galek-Aldridge | Health Sciences | Best Scholar Award

University Medical Center Utrecht | Netherland

Michał Gałek-Aldridge is a multilingual medical researcher and physician with a strong interdisciplinary background bridging molecular science, engineering, and regenerative medicine. Born on September 18, 1993, in Tucson, Arizona, he holds Polish nationality and is fluent in English, Dutch, Polish, and Russian, with advanced proficiency in French and beginner-level Portuguese. Michał’s academic journey spans multiple international institutions, including The British School of Warsaw, the Anglo-American School in Moscow, and the International School of Amsterdam, culminating in an International Baccalaureate (IB) bilingual diploma in 2011. He pursued a Bachelor of Science in Molecular Science and Technology at Delft University of Technology and Leiden University, completing his thesis on “The loading of chemotherapeutics in polymersome carriers” at the Reactor Institute Delft. During this period, Michał received an Erasmus Mundus scholarship to study at Chalmers University in Sweden, where he expanded his expertise in nuclear chemistry, project management, waste management, and ecology. Driven by a passion for medicine, he subsequently earned both a Bachelor and Master of Science in Medicine at the University of Amsterdam, with clinical experience in orthopedic surgery at the UMC Amsterdam. Since 2021, Michał has been a PhD candidate at the University Medical Center Utrecht, focusing on the translation of regenerative surgical shoulder implants into clinical practice. His research integrates advanced therapies, 3D-printed medical devices, and regenerative medicine, while also addressing regulatory compliance, intellectual property assessment, and GMP evaluation for ATMP production. He actively supervises students at the 3D Lab, contributing to both academic and translational research. His work is supported by prominent supervisors including Prof. Michel van den Bekerom, Dr. Arthur van Noort, Dr. Bart van der Wal, and Prof. Jos Malda. Michał has contributed extensively to the scientific literature, publishing as first author on innovative orthopedic treatments and as co-author in high-impact journals, including The Lancet Respiratory Medicine, Journal of Shoulder and Elbow Surgery, and JSES Reviews, Reports & Techniques. His research has spanned topics from patient-specific bone regenerative implants and congenital hip dislocation management to COVID-19 respiratory subphenotypes and ventilation strategies. Michał’s professional development is complemented by diverse certifications and conferences, including Medical Device Regulation (EU MDR 2018), ISO 13485, 3D printing in hospitals, and arthroscopy and arthroplasty courses. Outside of his professional endeavors, he maintains an active lifestyle through kickboxing, Muay Thai, skiing, kite surfing, and cooking. His combination of scientific rigor, clinical expertise, and entrepreneurial initiative positions him as a rising leader in regenerative medicine and medical innovation.

Profile: Scopus

Featured Publications

van Spanning, S. H., van Iersel, T. P., Verweij, L. P. E., van Noort, A., Floor, S., Galek-Aldridge, M., van den Borne, M. P. J., Kleinlugtenbelt, Y. V., van den Bekerom, M. P. J., & van Deurzen, D. F. P. (2025). Lower education level is associated with failure to return to sport whereas bony Bankart lesions predict successful return to preinjury sport level after open Latarjet procedure. Arthroscopy: The Journal of Arthroscopic & Related Surgery. Advance online publication.

 

Jinhua Zhu | Separation Sciences | Best Researcher Award

Published on by Research Awards

Prof Dr. Jinhua Zhu | Separation Sciences | Best Researcher Award 

Prof Dr. Jinhua Zhu | Henan University | China

Prof. Dr. Jinhua Zhu, a distinguished Professor and Doctoral/Master’s Supervisor at Henan University, is recognized as an Outstanding Youth of Henan Province. Her research centers on life separation science and the theory and application of chromatography technology, with impactful contributions in active component screening and functional drug delivery systems. She has published extensively in leading journals and has led numerous national and provincial research projects, advancing both theoretical and applied aspects of analytical chemistry.

Author Profile
Orcid

Education

Prof. Dr. Jinhua Zhu began her academic journey with a strong foundation in chemistry, cultivating an early passion for scientific inquiry and innovation. Her undergraduate studies provided her with a comprehensive understanding of core chemical principles, analytical thinking, and practical laboratory skills. This academic base ignited her curiosity in analytical chemistry, encouraging her to pursue advanced research in the field. As she progressed into doctoral studies, she immersed herself deeply in the study of separation science, chromatography, and applied chemical methodologies. Her doctoral training not only sharpened her research abilities but also nurtured her interest in solving real-world challenges related to drug discovery, environmental monitoring, and biochemical analysis. These formative years set the stage for her emergence as a respected academic, shaping her professional identity and building the foundation for her future contributions.

Experience

After completing her academic preparation, Prof. Zhu embarked on a professional journey that showcased her dedication to both teaching and research. She began her career in higher education, taking on roles that balanced classroom instruction with laboratory exploration. Her teaching portfolio has grown to include key undergraduate and graduate courses such as Instrumental Analysis, Separation Technology, and Modern Environmental Analysis Technology. Through these courses, she has not only transferred technical knowledge but also instilled scientific curiosity and critical problem-solving skills in her students. Alongside teaching, she pursued postdoctoral research, gaining deeper insights into advanced chemical analysis and international exposure through academic exchange programs. Her visiting scholarship abroad further broadened her scientific vision, allowing her to connect with global research trends and establish meaningful collaborations. Over time, her professional trajectory advanced steadily, reflecting her commitment to both academic excellence and innovative research leadership.

Research Focus

At the core of Prof. Zhu’s work lies her extensive contribution to life separation science and chromatography technology. Her research delves into both theoretical advancements and practical applications, making her work highly impactful in modern analytical chemistry. She has been particularly dedicated to the screening of bioactive components with hypoglycemic and anti-inflammatory properties, which has significant implications for therapeutic drug development. Another important dimension of her research is the construction and application of functional drug delivery systems, aimed at enhancing the effectiveness and precision of medical treatments. By combining fundamental chemical principles with applied research goals, Prof. Zhu bridges the gap between laboratory research and societal needs. Her publications in respected journals such as Separation and Purification Technology, Analytica Chimica Acta, Colloids and Surfaces B, and Talanta reflect her ability to contribute knowledge that is both novel and widely recognized in the scientific community.

Accolades and Recognition

Prof. Zhu’s academic journey has been marked by numerous awards, grants, and recognitions that highlight her leadership in chemistry and separation science. She has successfully led a variety of funded research projects, ranging from national-level grants to provincial programs that underscore her innovative contributions. Being recognized as an Outstanding Youth of Henan Province reflects not only her academic achievements but also her role as a model for emerging researchers in her region. These honors demonstrate her ability to consistently produce high-quality research, mentor the next generation of chemists, and push the boundaries of analytical methodologies. Her leadership in securing key projects at both national and provincial levels stands as testimony to her expertise, trustworthiness, and scientific vision.

Impact and Influence

The influence of Prof. Zhu extends beyond academic publications and research projects—her impact resonates within the broader scientific community and in real-world applications. Her work in drug delivery systems and natural product analysis offers pathways toward improved medical therapies, addressing health challenges such as diabetes and inflammation-related diseases. By developing innovative chromatography technologies, she has provided researchers with more efficient and precise analytical tools that can be applied in pharmaceutical, environmental, and food sciences. As a mentor and teacher, she has inspired numerous students, cultivating a culture of curiosity, discipline, and innovation in scientific practice. Her dual role as a researcher and educator ensures that her influence is both immediate in advancing scientific frontiers and long-lasting through the students she continues to guide.

Publication

Dual-monomer magnetic molecularly imprinted polymer for highly efficient luteolin separation from natural products.

Author: Yunfeng Yuan, Xiaoqi Liu, Chenjia Jiang, Haodong Zhou, Jinhua Zhu, Abdelhadi El Jaouhari, Xiuhua Liu, Minghua Lu*
Journal: Separation and Purification Technology,
Year: 2025

Three-dimensional ordered macro-microporous ZIF-8-α-Glu microreactors for α-glucosidase inhibitors screening from green tea.

Author: Xiaoqi Liu, Haodong Zhou, Chenjia Jiang, Yunfeng Yuan, Jinhua Zhu, Minghua Lu*
Journal: Talanta
Year: 2025

Phenylboronic acid functionalized magnetic ferroferric oxide nanoparticles and capillary electrophoresis for efficient isolation of flavonoid compounds from leaves of Lonicera japonica Thunb.

Author: Chenjia Jiang, Xiaoqi Liu, Yunfeng Yuan, Haodong Zhou, Jinhua Zhu, Minghua Lu*
Journal: Chromatography A,
Year: 2025

Conclusion

Prof. Dr. Jinhua Zhu stands as a leading figure in the field of analytical and separation science, with her research bridging theoretical chemistry and real-world biomedical applications. Through her pioneering work in chromatography, bioactive compound screening, and functional drug delivery systems, she has advanced both scientific knowledge and practical healthcare solutions. Her impactful publications, successful research leadership, and dedication to mentoring young scholars highlight her as a role model in academia. With continued innovation and global collaborations, Prof. Zhu’s contributions are set to leave a lasting legacy, shaping the future of separation science and strengthening its role in improving human health and well-being.

Jitendra Patil | Health Sciences | Best Researcher Award

Published on by Research Awards

Mr. Jitendra Patil | Health Sciences | Best Researcher Award

Mr. Jitendra Patil | Sankalchand Patel University Visnagar,Badoda | India

Mr. Jitendra Hilal Patil, Lecturer at H.R. Patel Institute of Pharmaceutical Education and Research, Shirpur, is a PCI-registered academic with a strong background in pharmaceutical sciences and nanotechnology. He holds an M.Pharm in Quality Assurance and is pursuing his Ph.D. at Sankalchand Patel University, Visnagar. His research focuses on developing pH-responsive nanocarrier drug delivery systems for targeted cancer therapy, with publications in Scopus-indexed journals and one patent under process. With a citation index of 29, his innovative work contributes significantly to advancing precision medicine while minimizing systemic toxicity in anticancer treatments.

Author Profile 

Scopus

Education

From the very beginning of his educational journey, Mr. Jitendra Hilal Patil demonstrated a keen interest in pharmaceutical sciences and biomedical research. His strong academic foundation was built through consistent excellence across secondary and higher secondary education, which he pursued with dedication and discipline. His pursuit of a Bachelor’s and Master’s degree in Pharmacy further sharpened his knowledge in drug formulation, quality assurance, and advanced pharmaceutical principles. These formative academic years not only shaped his scientific mindset but also ignited his passion for research in nanotechnology and innovative drug delivery systems. His pursuit of a Ph.D. reflects his commitment to expanding the boundaries of knowledge and contributing to global healthcare challenges.

Experience

Mr. Patil serves as a Lecturer at H.R. Patel Institute of Pharmaceutical Education and Research, Shirpur, where he plays a pivotal role in nurturing future pharmacists and researchers. His teaching approach integrates theory with practical insights, encouraging students to think critically about real-world healthcare challenges. Alongside his teaching responsibilities, he actively engages in research, ensuring his academic contributions are aligned with the latest developments in pharmaceutical innovation. His ability to balance teaching, research, and mentoring highlights his versatility as both an educator and a researcher. He also ensures his students are exposed to cutting-edge topics such as nanotechnology, targeted therapies, and drug delivery systems, preparing them to excel in the evolving landscape of pharmaceutical sciences.

Research Focus

The hallmark of Mr. Patil’s academic journey lies in his research on pH-responsive nanocarrier drug delivery systems designed for targeted cancer treatment. Recognizing the limitations of conventional chemotherapy—such as poor survival rates, systemic toxicity, and severe side effects—he focused on developing titanium-based metal-organic frameworks (Ti-MOFs) as nanocarriers for the anticancer drug axitinib (AXT).

Through advanced hydrothermal synthesis and characterization techniques, he successfully developed stable, porous nanostructures that exhibit excellent pH-responsive behavior. His in vitro studies revealed that these carriers released minimal drug amounts in neutral pH, simulating healthy tissues, but significantly increased release in acidic environments mimicking cancer cells. This innovation represents a major step toward precision medicine, offering the potential to reduce toxicity and enhance therapeutic efficacy. His work exemplifies how nanotechnology can transform oncology treatments, opening doors to more effective and patient-friendly therapies.

Awards and Recognition

Mr. Patil’s research has garnered recognition through Scopus-indexed publications, citations, and a patent under process, highlighting the originality and applicability of his work. With a citation index of 29, his publications demonstrate a meaningful academic impact and a growing influence in the pharmaceutical research community. He is also a registered member of the Pharmacy Council of India (PCI), further strengthening his professional credibility. While he has not yet accumulated multiple industry consultancy projects or editorial appointments, his promising work and contributions reflect the qualities of a rising researcher who is set to achieve even greater recognition at both national and international levels.

Impact and Influence

The potential impact of Mr. Patil’s research extends beyond academia, offering transformative possibilities in cancer treatment. By addressing the challenges of drug toxicity and inefficient targeting, his nanocarrier-based system has the potential to improve the quality of life for patients undergoing therapy. Moreover, his contributions set a strong foundation for future collaborations in nanomedicine, oncology research, and pharmaceutical technology. His influence also extends to his students, who benefit from his mentorship, guidance, and emphasis on research-driven learning. By bridging the gap between classroom knowledge and practical innovation, he inspires a new generation of pharmaceutical professionals to pursue impactful research that addresses pressing healthcare challenges.

Publications

Nonlocal thermoelastic diffusion analysis in a semi-infinite body subjected to thermal loading with memory effects.

Author: Jitendra Patil, Chandrakant Jadhav, Nitin Chandel & Vinod Varghese
Journal: Archive of Applied Mechanics
Year: 2025

Development and Characterization of AXT@Metal-Organic Framework: A Biocompatible, pH-Responsive Nanocarrier for Targeted Axitinib Delivery in MCF-7 Cancer Cells.

Author: Jayvadan K. Patel, Ujashkumar A. Shah, Pravin O. Patil, Jitendra H. Patil
Journal: Annales Pharmaceutiques Françaises
Year: 2025

Conclusion

Mr. Jitendra Hilal Patil exemplifies the qualities of a dedicated educator, an emerging researcher, and an innovator in pharmaceutical sciences. His academic journey, professional commitments, and research on pH-responsive nanocarriers reflect not only his scientific expertise but also his vision for improving global healthcare outcomes. With a growing body of impactful publications, a patent under process, and recognition as a promising voice in nanotechnology and drug delivery research, he continues to inspire both peers and students alike. Looking forward, his unwavering dedication positions him to make enduring contributions that bridge cutting-edge research with tangible benefits for society, leaving a meaningful legacy in academia and beyond.

Dengning Xia | Pharmacology | Best Researcher Award

Published on by Research Awards

Prof. Dengning Xia | Pharmacology | Best Researcher Award 

Prof. Dengning Xia, Sun Yat-sen University, China

Dr. Dengning Xia is an Associate Professor and Principal Investigator at the School of Pharmaceutical Sciences (Shenzhen), Sun Yat-sen University, China. With a Ph.D. in Pharmaceutics and international training experience in Denmark and the U.S., his research focuses on industrial pharmaceutics, biopharmaceutics, and biomedical engineering for drug and vaccine delivery. His work explores microneedle systems, nucleic acid and oral delivery, and translational drug formulation. He has received numerous talent awards, serves on editorial boards of leading journals, and has published over 40 peer-reviewed papers in top-tier pharmaceutical and biomedical journals.

Author Profile

Google  Scholar

🎓 Early Academic Pursuits

Dr. Dengning Xia’s academic journey reflects a strong and consistent commitment to the pharmaceutical sciences. He began his higher education with a Bachelor’s degree in Pharmacy from the School of Pharmacy, Hunan University of Chinese Medicine in 2005. Demonstrating early promise and dedication, he continued his studies with a Master’s degree in Pharmaceutics from West China School of Pharmacy, Sichuan University (2005–2008), a program known for its rigorous training and focus on drug delivery systems. Pushing the boundaries of academic excellence, Dr. Xia earned his Ph.D. in Pharmaceutics from Shenyang Pharmaceutical University (2008–2011). As part of his doctoral training, he participated in a joint research program at the University of Copenhagen in Denmark (2011), gaining valuable international research exposure and advancing his expertise in advanced drug delivery systems. His early academic experiences laid the foundation for a research career focused on innovation in pharmaceutical technologies.

🧪 Professional Endeavors

Dr. Xia’s professional journey spans globally recognized institutions and industry positions, reflecting his deep-rooted experience across both academic and applied pharmaceutical sciences. Following a brief stint as Formulation Project Leader at Shanghai Haini Pharmaceutical Co., Ltd. (2011–2012), he moved into academia and research as a Postdoctoral Fellow and later Associate Researcher at the Shanghai Institute of Materia Medica, Chinese Academy of Sciences (2012–2017). His passion for translational research took him to the United States, where he worked at the University of Connecticut and later as a Postdoctoral Fellow and Research Scientist at the School of Chemical and Biomolecular Engineering, Georgia Institute of Technology (2017–2020). Since 2020, Dr. Xia has been serving as an Associate Professor (PI) at the School of Pharmaceutical Sciences (Shenzhen), Sun Yat-sen University, a role he assumed under the prestigious “Hundred Talents Program.”

🔬 Contributions and Research Focus

Dr. Xia’s research spans industrial pharmaceutics, biopharmaceutics, and biomedical engineering, with a consistent focus on overcoming biological barriers in drug and vaccine delivery. His multidisciplinary work has led to impactful contributions in the following areas:

  1. 🧬 Overcoming Biological Barriers in Drug Delivery: He has developed innovative microneedle technologies, gastrointestinal and ocular drug delivery systems, and long-acting formulations that enhance therapeutic efficacy while minimizing toxicity.

  2. 💉 Vaccine and Nucleic Acid Delivery Systems: Leveraging cutting-edge piezoelectric systems and novel carriers, Dr. Xia is pioneering advancements in gene and vaccine delivery platforms, including low-cost electroporators and skin-based delivery.

  3. 🏥 Clinical Translation: His translational research bridges laboratory discoveries with clinical applications, facilitating the development of scalable pharmaceutical formulations and devices.

With over 40 high-impact publications, including in PNAS, Advanced Functional Materials, Journal of Controlled Release, and Science Robotics, Dr. Xia’s work is globally cited and well-respected.

🏆 Accolades and Recognition

Dr. Xia’s innovative work has earned him numerous awards and prestigious appointments:

  • “Pearl River Talents Program” Young Top-notch Talent – Guangdong Province

  • Pengcheng Peacock Plan – High-level Talent, Shenzhen

  • Outstanding Young Talent – Sanofi-CAS Shanghai Institute of Biological Sciences

  • Youth Innovation Promotion Association Member – Chinese Academy of Sciences

He serves on editorial boards for top journals such as the European Journal of Pharmaceutics and Biopharmaceutics and Asian Journal of Pharmaceutical Sciences, and is a trusted peer reviewer for over 10 major journals and national grant programs.

🌍 Impact and Influence

Dr. Xia’s work has significantly advanced the field of drug delivery science, particularly through his innovations in microneedle patches, oral and ocular formulations, and nucleic acid therapeutics. His research not only addresses practical clinical challenges but also offers low-cost, accessible solutions for global healthcare, such as vaccine patches for diseases like SARS-CoV-2 and Ebola. His collaborative projects with international scientists from the U.S., China, and Europe have amplified his impact, making him a key influencer in pharmaceutical formulation research and a valuable mentor to the next generation of scientists.

🧭 Legacy and Future Contributions

Looking ahead, Dr. Xia’s legacy will likely be defined by his ability to combine academic rigor with real-world solutions. His contributions to microneedle-based technologies and oral delivery systems are poised to transform how vaccines and drugs are administered, especially in low-resource settings. As a principal investigator and educator at Sun Yat-sen University, he continues to mentor emerging scientists, foster international collaborations, and push the boundaries of what’s possible in drug delivery science. With his track record, Dr. Xia is set to play a leading role in the next generation of pharmaceutical innovation, particularly in the realms of biodegradable drug carriers, smart delivery systems, and personalized medicine.

✍️Publication Top Notes

📘Preparation of stable nitrendipine nanosuspensions using the precipitation–ultrasonication method for enhancement of dissolution and oral bioavailability

Author: D Xia, P Quan, H Piao, H Piao, S Sun, Y Yin, F Cui

Journal: European journal of pharmaceutical sciences 

Year: 2010

📘Devices, Systems, and Methods for Facilitating Tissue Delivery of Drug

Author: MS Bhamla, G Byagathvalli, D Xia, MR Prausnitz

Journal: US Patent App

Year: 2023

📘Inflammation-retentive hyaluronic acid-mesalamine conjugate for enhanced oral therapy in ulcerative colitis

Author: Y Hou, J Yao, J Hu, D Xia

Journal: International Journal of Biological Macromolecules

Year: 2025